|
 |
Xeloda capecitabineThis page contains recent news articles, when available, and an overview of Xeloda capecitabine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Roche announced today that it has submitted an application to the European Medicines Agency (EMEA) to extend the label of Xeloda (capecitabine) for use in ... Pharmaceutical Processing Gut Reaction - Dec 23, 2009 Among the 22 percent of them whose tumors overproduced HER2, almost 600 patients received a chemotherapy regimen of Xeloda (capecitabine) or 5-fluorouracil, ... Curetoday.com (press release) Herceptin receives positive opinion in record time for the treatment of HER2 ... - Dec 19, 2009 Xeloda (capecitabine) is a highly effective targeted oral chemotherapy offering patients a survival advantage when taken on its own or in combination with ... PipelineReview.com (press release) Tykerb/Herceptin combination extends survival by 4 months plus - Dec 15, 2009 Tykerb is currently indicated in combination with Xeloda (capecitabine, Roche) for the treatment of patients with advanced or metastatic breast cancer whose ... Pharma Times ìœ ë°©ì•” 약물 병용효과 ë˜? 나와 - Dec 13, 2009 ...ë˜? 지난 2007ë…„, 허셉틴과 'ì ¤ë¡œë‹¤'(Xeloda, capecitabine) 병용시ì—?ë?„ 효과가 있다는 주장ë?„ 나온바 있어 ì‹ ì„ ë?„는 떨어지는 편ì?´ë‹¤. 헬스코리아뉴스 Clinic Roundup - Nov 11, 2009 ...recurrence taking Xeloda (capecitabine) as part of their chemotherapy regimen had a 34 percent reduction in the risk of the cancer returning or death. ... Therapeutics Daily (press release) (registration) 위암 ì¹˜ë£Œì œ 시장 10ë…„ë’¤ 2ë°° 성장 - Nov 12, 2009 ...특히 로슈ì?˜ 허셉틴, 아바스틴, 'ì ¤ë¡œë‹¤'(Xeloda, capecitabine)는 2018ë…„ 매출ì?˜ 1/3ì?„ ì ?ìœ í• ê²ƒìœ¼ë¡œ 기대ë?œë‹¤. 단, 2012ë…„ì—?는 허셉틴ì?˜ ë°”ì?´ì˜¤ì‹œë°€ëŸ¬ê°€, ... 디지틀보사 … ) In Combination With Xeloda® (Capecitabine) For The Treatment Of … - Mar 19, 2007 GlaxoSmithKline plc [NYSE: GSK, LSE: GSK] announced today that the United States Food and Drug Administration (FDA) approved TYKERB® (lapatinib), ... Medical News Today - Medical News Today (press release) What Can Xeloda (Capecitabine) Add to Neoadjuvant Chemotherapy?: … - Feb 22, 2006 By Chris Berrie. VIENNA, AUSTRIA -- February 22, 2006 -- Data from completed and ongoing trials showing survival benefits with capecitabine (Xeloda(R)) ... DG News Xeloda (Capecitabine) Plus Xelox (Oxaliplatin) Dramatically Reduces … - Nov 3, 2005 PARIS, FRANCE -- November 3, 2005 -- New data confirm that Xelox, a combination of Xeloda® (capecitabine) and oxaliplatin, is as safe as the current ... DG News Health Canada Approves Xeloda (Capecitabine) for Adjuvant Therapy in ... - Mar 28, 2006 MISSISSAUGA, CANADA -- March 28, 2006 - Hoffmann-La Roche Ltd. announced today that Health Canada has approved Xeloda (capecitabine), an innovative oral ... DG News Xeloda - Capecitabine - Medical Drug - Aug 2, 2007 Xeloda is used in the treatment of advanced or metastatic colorectal cancer. It can also be used to treat advanced or metastatic breast cancer when ... Virtual Medical Centre - The Virtual Medical Centre Article: When all else fails, consider capecitabine for SCC.(Cutaneous... - Jul 1, 2008 When all else fails, consider capecitabine for SCC.(Cutaneous Oncology) ... find Skin & Allergy News articles. VANCOUVER, BC -- Capecitabine, an oral ... Pay-Per-View - Skin & Allergy News - HighBeam Research Study boosts Roche's Avastin in breast cancer - Nov 24, 2008 ZURICH (Reuters) - Roche Holding AG (ROG.VX), the world's largest maker of cancer drugs, said on Monday that Avastin met its primary endpoint in a Phase III ... Reuters The clinical and economic benefits of capecitabine and tegafur with... - Apr 17, 2007 With reference to the study by Ward et al (2006), the article compares the cost effectiveness of oral fluoropyrimidine treatment for mCRC vs intravenously ... Nature.com ECCO: Xeloda-Gemzar Duo Extends Pancreatic Cancer Survival - Nov 3, 2005 By Neil Osterweil, Senior Associate Editor, MedPage Today. PARIS, Nov. 3 - The addition of Xeloda (capecitabine) to Gemzar (gemcitabine) can significantly ... MedPage Today Press Release: Xeloda Meets Primary Endpoint in Multinational Phase... - Dec 11, 2006 Xeloda Meets Primary Endpoint in Multinational Phase III Advanced Colorectal Cancer Study. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Results Show XELOX (Xeloda(R) plus oxaliplatin) … - Jan 22, 2007 Results Show XELOX (Xeloda(R) plus oxaliplatin) Provides Equivalent Overall Patient Survival Compared to FOLFOX in Advanced Colorectal Cancer. from PR ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Large International Phase III Trial in Metastatic... - Jul 31, 2006 Large International Phase III Trial in Metastatic Colorectal Cancer Meets Primary Endpoints for XELOX (Xeloda(R) + Oxaliplatin) and for Avastin. from PR ... Pay-Per-View - PR Newswire - HighBeam Research Xeloda plus oxaliplatin (XELOX) dramatically reduces hospital visits... - Nov 2, 2005 An abbreviation for a type of combination chemotherapy used to treat colorectal cancer; it contains Xeloda (capecitabine) and oxaliplatin. ... eurekalert.org Press Release: Benefits of Oral Xeloda Over Continuous Intravenous … - Jan 7, 2008 Benefits of Oral Xeloda Over Continuous Intravenous Chemotherapy Confirmed for Advanced Stomach Cancer. from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Xeloda(R) Plus Cisplatin Combination Effective in … - Jun 5, 2006 Xeloda(R) Plus Cisplatin Combination Effective in Patients with Advanced Gastric Cancer. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Oral Chemotherapy Xeloda Shown to Extend Survival for Patients with … - Nov 2, 2005 NUTLEY, NJ, Nov. 2 /PRNewswire/ -- The interim analysis of one of the largest phase III studies investigating the first-line treatment of advanced ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Xeloda(R) Combination Meets Primary Endpoint in … - Dec 11, 2006 034 advanced colorectal cancer patients that ... line XELOX (Xeloda + oxaliplatin ... used to treat colorectal cancer; it contains Xeloda (capecitabine ... Pay-Per-View - PR Newswire - HighBeam Research Xeloda Shows Strong Promise in Early Breast Cancer = - Dec 14, 2008 Data presented today indicate that adding Xeloda to standard chemotherapy allows women to live cancer-free for longer. Preliminary data presented at the ... ots.at Colon Cancer, Xeloda plus oxaliplatin (XELOX) dramatically reduces … - Nov 8, 2005 New data confirm that XELOX, a combination of Xeloda® (capecitabine) and oxaliplatin, is as safe as the current standard treatment of intravenous ... Medical News Today - Medical News Today (press release) X-ACT confirms Xeloda efficacy in bowel cancer. - Oct 8, 2007 Five-year overall survival data from the X-ACT trial comparing Swiss drug major Roche's Xeloda (capecitabine) against standard adjuvant chemotherapy ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Roche Pharmaceuticals - Jul 1, 2008 Basel, Switzerland (ots/PRNewswire) - - For non US or non UK Media Only - Oral Chemotherapy Tablet Option Reduces the Time Patients Need to Spend in the ... presseportal.ch NICE Says Yes To 'no Wait' Oral Bowel Cancer Treatment Xeloda (REG) (... - Apr 27, 2006 Bowel cancer patients are to be given access to the 'smart pill' Xeloda (capecitabine) that could save financially-stretched NHS cancer services £22 ... Medical News Today - Medical News Today (press release) Xeloda wins EU approval for adjuvant therapy in colon cancer treatment - Apr 1, 2005 Roche announced today that the European authorities have approved Xeloda (capecitabine), an innovative oral chemotherapy, to be used as an adjuvant ... Medical News Today - Medical News Today (press release) GSK gets FDA nod for cancer drug - Apr 15, 2007 GlaxoSmithKline received an approval for Tykerb (lapatinib), in combination with Xeloda (capecitabine), for the treatment of patients with advanced or ... Express Pharma Oral combination chemo may extend survival - Jan 7, 2008 NUTLEY NJ – Jan. 7, 2008 – Patients with cancer of the esophagus may survive longer with a combination oral chemotherapy regimen a new study published in ... Cancerfacts.com Biweekly Xeloda® Dosing Regimen Is Well Tolerated in Advanced Breast … - Jun 6, 2007 Results of the first ever study of biweekly Xeloda® (capecitabine) in metastatic breast cancer patients demonstrated that a seven-days-on/seven-days-off ... webwire.com Largest Ever Data Set Shows Consistent Benefits With Avastin When … - Jun 5, 2006 New data from 4000 patients show that Avastin (bevacizumab rhuMAb-VEGF) enables patients with advanced colorectal cancer (CRC) to live longer without ... Newswit.com Press Release: Nearly 60 New Studies of Oral Xeloda(R) (capecitabine)... - May 22, 2008 Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research The clinical and economic benefits of capecitabine and tegafur with... - Jun 15, 2005 Two oral fluoropyrimidine therapies have been introduced for metastatic colorectal cancer. One is a 5-fluorouracil pro-drug, capecitabine; the other is a ... Nature.com Access Granted for New Treatment Option for Scots With Stomach Cancer - Sep 10, 2007 WELWYN GARDEN CITY, SCOTLAND -- September 10, 2007 -- Today the Scottish Medicines Consortium has confirmed the efficacy and cost effectiveness of oral ... DG News Bowel cancer pill for home treatment - Oct 14, 2008 A drug to help fight the third most common cancer north of the border has been approved for widespread use by the NHS in Scotland. ... The Herald Xeloda plus Avastin show clinical benefit. - Dec 25, 2006 Xeloda plus Avastin show clinical benefit. An interim analysis of the XCALIBr trial suggests that first-line therapy with a combination of Swiss drug major ... $9.94 - Pharma Marketletter - Alacra Store Press Release: Review Publication Confirms the Benefits of Highly … - Nov 20, 2007 Review Publication Confirms the Benefits of Highly Effective Oral Cancer Drug Xeloda(R) (capecitabine) Over Intravenous Chemotherapy in Advanced Breast ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: FDA Approves Oral Xeloda(R) for the Adjuvant Treatment... - Jun 15, 2005 FDA Approves Oral Xeloda(R) for the Adjuvant Treatment of Colon Cancer. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Xeloda Meets Primary Endpoint in Multinational Phase III Advanced … - Nov 12, 2006 Roche announced today that a large, international Phase III study (NO16967) of 627 previously treated patients with advanced colorectal cancer met its ... presseportal.de Roche gets EU approval for wider Avastin use - Jan 28, 2008 By Sven Egenter. ZURICH, Jan 28 (Reuters) - Swiss drugmaker Roche's (ROG.VX) key cancer drug Avastin has received approval for wider use in the European ... Reuters Review Publication Confirms the Benefits of Highly Effective Oral... - Nov 20, 2007 A review paper in Annals of Oncology now published on-lineconcludes that the oral cancer drug Xeloda (capecitabine) offers aneffective and more cost- ... Med-Kolleg Colon Cancer; FDA approves oral Xeloda for the adjuvant treatment of ... - Jul 11, 2005 2005 JUL 11 - (NewsRx.com) -- Roche announced that the US Food and Drug Administration (FDA) has approved Xeloda (capecitabine) - an oral chemotherapy - for ... Pay-Per-View - Clinical Oncology Week - Factiva, from Dow Jones Roche Pharmaceuticals - Mar 6, 2006 Basel, Switzerland (ots/PRNewswire) - - Real World Practice Confirms Avastin's Efficacy and Safety in Advanced Colorectal Cancer New data from 4000 patients ... presseportal.ch EU Grants Broad Approval Of Xeloda For Patients With Metastatic … - Feb 5, 2008 Roche announced that the European Commission has approved its oral chemotherapy Xeloda (capecitabine) for the treatment of metastatic colorectal cancer in ... Medical News Today - Medical News Today (press release) Roche's Xeloda performs well in Ph III - Apr 10, 2006 Swiss firm Roche says that a Phase III study of its drug Xeloda (capecitabine) as a treatment for advanced gastric cancer has met its primary endpoint. ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Roche's Xeloda improves survival.(Brief Article) - Nov 7, 2005 Swiss drug major Roche says that its oral anticancer drug Xeloda (capecitabine) extended survival in pancreatic cancer patients, according to Phase III data ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Press Release: Xeloda XeNA Study Analyses of Xeloda, Docetaxel and … - Sep 7, 2007 Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Over 30 New Studies of Oral Xeloda(R) Featured at the ... - Jan 25, 2008 Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Article: Capecitabine for stage III colon ca.(CLINICAL CAPSULES)(colon... - Aug 15, 2005 Capecitabine for stage III colon ca.(CLINICAL CAPSULES)(colon cancer)(Brief Article) ... find Internal Medicine News articles. Pay-Per-View - Internal Medicine News - HighBeam Research GSK – Tykerb has promise in treating breast cancer - Dec 28, 2006 New trial data show the need for further work on Tykerb (lapatinib) in patients with HER2-positive breast cancer, according to GlaxoSmithKline (GSK). ... Hays Pharma Roche Submits Application to the FDA for use of XELOX (Xeloda® plus … - Mar 31, 2007 Roche announced the submission of a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for the use of Xeloda® ... webwire.com Want a zillion-dollar cure idea? - Aug 15, 2008 By Monique Doyle Spencer. It was a 23-year-old medical student, Ernest Duchesne, who discovered penicillin 32 years before Alexander Fleming. ... New York Times Oral chemotherapy option soon for cancer - Apr 18, 2006 By IANS, [RxPG] Swiss pharmaceutical major Roche's study investigating Xeloda (capecitabine) in the first-line treatment of advanced stomach cancer has ... RxPG NEWS Press Release: Xeloda(R) Combination Therapy in Esophagogastric … - Jan 7, 2008 Phase III study in advanced esophagogastric cancer, were presented at the American ... showing that its anticancer drug Xeloda (capecitabine) can replace ... Pay-Per-View - PR Newswire - HighBeam Research FDA approves oral Xeloda for the adjuvant (after surgery) treatment... - Jun 19, 2005 Roche announced that the US Food and Drug Administration (FDA) has approved Xeloda (capecitabine), an innovative oral chemotherapy, for the adjuvant ... Medical News Today - Medical News Today (press release) Tablet Is Better All Round For Cancer Patients - Oct 12, 2007 A drug to treat colon cancer is proving much more convenient than traditional chemotherapy, has fewer side effects - and is giving patients a better chance ... emaxhealth.com Capecitabine Plus Cisplatin Combination Effective in Patients With … - Jun 19, 2006 ATLANTA, GA -- June 19, 2006 -- In the first-ever phase 3 trial of oral Xeloda (capecitabine) as first-line treatment for gastric cancer, ... DG News FDA Allows Phase II Trial of Breast Cancer Candidate - Jan 30, 2008 German drugmaker Wilex will conduct a Phase II trial with WX-671 in combination with the chemotherapeutic agent Xeloda in patients with HER2-receptor ... FDA news - FDA news (subscription) Esophageal Cancer News - Jan 2, 2007 Two recent studies presented at the 2006 meeting of the American Society for Therapeutic Radiation and Oncology (ASTRO) suggest that Erbitux® (cetuximab) ... Cancer Consultants Press Release: New Study With Xeloda Demonstrates Important Survival ... - Oct 31, 2005 New Study With Xeloda Demonstrates Important Survival Benefit for Women With Breast Cancer. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research New drug for breast cancer boosts GSK - Apr 4, 2006 By Sam Lister, Health Correspondent. TRIALS of a breast cancer drug targeting tumours that fail to respond to Herceptin have been stopped early because the ... Times Online Glaxo says new drug effective against advanced breast cancer - Jun 3, 2006 An experimental drug combined with chemotherapy has proved effective in slowing down advanced breast cancer, which no longer responds to other treatments, ... Turkish Press Roche To Present Data Showing Progress In Treating Lung, Gastric And ... - Sep 12, 2008 More than 100 Roche abstracts have been accepted for the biggest cancer congress in Europe, the European Society for Medical Oncology (ESMO), which opens in ... Medical News Today - Medical News Today (press release) Press Release: Biweekly Xeloda(R) Dosing Regimen is Well Tolerated in... - Jun 2, 2007 Biweekly Xeloda(R) Dosing Regimen is Well Tolerated in Advanced Breast Cancer. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research New data show Enzastaurin's activity across multiple cancer cell lines - Jun 5, 2006 Eli Lilly and Company's enzastaurin, an investigational, multi-targeted therapy that is currently the focus of two global Phase III clinical trials, ... News-Medical.net GSK halts enrollment after Tykerb exceeds expectations in breast... - Apr 3, 2006 UK drug major GlaxoSmithKline says that, following advice from an Independent Data Monitoring Committee, it has halted further enrollment in a Phase III ... $4.95 - Pharma Marketletter - ECNext FDA to review Tykerb as breast cancer therapy. - Sep 25, 2006 Specifically, the NDA covers the agent's use, in combination with Roche's Xeloda (capecitabine), as a therapy for advanced or metastatic HER2 positive ... Free with registration - Pharma Marketletter - AccessMyLibrary.com EU Grants Broad Approval of Xeloda for Patients With Metastatic … - Apr 2, 2008 Roche announced today that the European Commission has approved its oral chemotherapy Xeloda (capecitabine) for the treatment of metastatic colorectal ... presseportal.de Anybody want a zillion-dollar cure idea? - Aug 1, 2008 HOW DO people get a good idea noticed? It's not so easy. It was a 23-year-old medical student, Ernest Duchesne, who discovered penicillin 32 years before ... Boston Globe Herceptin Prolongs Progression Free Survival Of HER2 Breast Cancer … - May 30, 2008 The results of a phase III trial comparing Herceptin with chemo against chemo on its own showed that Herceptin helped women with aggressive metastatic ... Medical News Today - Medical News Today (press release) Xeloda® (capecitabine) als toevoeging standaard chemotherapie? - Dec 20, 2008 Als Xeloda® (capecitabine) wordt toegevoegd aan standaard chemotherapie in de behandeling van vrouwen met vroege borstkanker, neemt de kans op terugkeer van ... Medical facts Xeloda filed in Europe for treatment of advanced stomach cancer - Jul 21, 2006 Basel, 21 July 2006, The European Medicines Agency informed Roche today that the filing for a new indication in Europe for the oral cancer drug Xeloda ... webwire.com Roche's Oral Cancer Drug Effective Over Intravenous Chemotherapy - Nov 22, 2007 Roche has reported that its oral cancer drug Xeloda offers an effective and more cost-effective treatment option than current intravenous cytotoxic ... RedOrbit Roche Submits Application to the FDA for use of XELOX (Xeloda(R) plus... - Mar 26, 2007 NUTLEY, NJ, March 26 /PRNewswire-FirstCall/ -- Roche announced today the submission of a supplemental new drug application (sNDA) to the US Food and Drug ... Free with registration - PR Newswire - AccessMyLibrary.com Antisense—down, but not out - Apr 30, 2007 Looking to antisense for cures. Penguins at the Milwaukee County Zoo, ailing from West Nile virus, were treated with an antisense drug. ... Nature.com THE BIG C - Jun 15, 2006 By Madeleine Bailey 15/06/2006. Why it's no longer a death sentence MEDICAL BREAKTHROUGHS ARE INCREASING THE CHANCES OF SURVIVING OUR MOST FEARED DISEASES. ... Mirror.co.uk Abraxane in Combination with Xeloda Effective Against Metastatic... - Dec 14, 2006 According to results recently published at the 2006 San Antonio Breast Cancer Symposium (SABCS), Abraxane (albumin-bound paclitaxel) in combination with ... Cancer Consultants Cetuximab in metastatic colorectal ca.(CLINICAL CAPSULES)(Brief … - Apr 15, 2005 Cetuximab in metastatic colorectal ca.(CLINICAL CAPSULES)(Brief Article) ... find Internal Medicine News articles. Cetuximab appears to yield the same ... Pay-Per-View - Internal Medicine News - HighBeam Research XELODA MEETS PRIMARY ENDPOINT IN COLORECTAL CANCER … - Dec 11, 2006 Roche announced today that a large, international Phase III study (NO16967) of 627 previously treated patients with advanced colorectal cancer met its ... Free with registration - AsiaPulse News - AccessMyLibrary.com Results Show XELOX (Xeloda(R) Plus Oxaliplatin) Provides Equivalent … - Jan 22, 2007 NUTLEY, NJ, Jan. 22 /PRNewswire/ -- Overall survival results from an international, Phase III study (NO16966) suggest that XELOX (Xeloda(R) plus ... RedOrbit Avastin and Xeloda Set New Standards for the Treatment of First-Line ... - Oct 2, 2006 Results from an international, Phase III study presented for the first time today at the European Society for Medical Oncology (ESMO) meeting, show that two ... prnewswire.co.uk Avastin Achieves Impressive Rate of Curative Surgery in Patients With... - Sep 24, 2007 New data from the large international First BEAT trial unveiled today at the European Cancer Conference (ECCO) demonstrate that a high number of patients ... presseportal.de Pancreatic Cancer News - Nov 9, 2007 According to an article recently published in Annals of Oncology, different chemotherapy regimens may be similarly effective in the treatment of advanced ... Cancer Consultants Two Steps Forward in the Fight Against Breast Cancer - Sep 27, 2006 Greetings! I start my new position in San Francisco on October 3 so I am very excited by many things. There are two breast cancer items this month of note ... HealthCentral.com Patients with HER2-positive breast cancer significantly benefit from ... - Oct 3, 2006 Istanbul, Turkey, October 03 (PPI): New data presented at the European Society for Medical Oncology (ESMO) show that the addition of Xeloda (capecitabine) ... Free with registration - PPI - Pakistan Press International - AccessMyLibrary.com Xeloda(R) Plus Cisplatin Combination Effective in Patients with... - Jun 5, 2006 ATLANTA, June 5 /PRNewswire/ -- In the first-ever Phase III trial of oral Xeloda (capecitabine) as first-line treatment for gastric cancer, ... Free with registration - PR Newswire - AccessMyLibrary.com Novel Xeloda® Dosing Schedule May Offer Well-Tolerated Alternative... - Apr 21, 2008 A novel biweekly dosing schedule of Xeloda® (capecitabine) enabled safe delivery of higher daily doses in the treatment of advanced breast cancer, ... webwire.com Chemo pill produces equal survival - Sep 29, 2007 BARCELONA – Sept. 29, 2007 – Colon cancer patients who took a chemotherapy pill survived as long as patients who had standard intravenous chemotherapy a new ... Cancerfacts.com Press Release: Positive Xeloda(R) Five-Year Overall Survival Study... - Sep 25, 2007 Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting. from PR ... Pay-Per-View - PR Newswire - HighBeam Research Avastin and Xeloda Set New Standards for the Treatment of First-Line ... - Oct 4, 2006 Results from an international, Phase III study presented for the first time today at the European Society for Medical Oncology (ESMO) meeting, show that two ... Newswit.com Herceptin, Xeloda, Avastin Help Breast Cancer Patients - Dec 11, 2008 New data being presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) show that Herceptin (trastuzumab), Avastin (bevacizumab) and oral ... emaxhealth.com New England Journal of Medicine publishes landmark Xeloda X-ACT … - Jun 29, 2005 Landmark data published in prestigious New England Journal of Medicine of last week of Jun 2005 show that Xeloda (capecitabine), an innovative oral ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Results Show XELOX (Xeloda(R) plus oxaliplatin) Provides Equivalent … - Jan 21, 2007 NUTLEY, NJ, Jan. 22 /PRNewswire/ -- Overall survival results from an international, Phase III study (NO16966) suggest that XELOX (Xeloda(R) plus ... Genetic Engineering News - Genetic Engineering News (press release) Avastin and Xeloda Meet Primary Endpoints in Large Phase III First... - Jul 31, 2006 Roche announced today that a large, international Phase III study (NO16966) enrolling 2, 035 previously untreated metastatic colorectal patients met both ... Newswit.com Oral Cancer Drug Xeloda Receives Positive Opinion From The European … - Feb 26, 2007 Roche announced today that its innovative oral cancer drug Xeloda (capecitabine), in combination with platinum-based chemotherapy, has received a positive ... Medical News Today - Medical News Today (press release) New Breast Cancer Data Show Xeloda is as Effective as Anthracyclines... - Jun 5, 2006 A new randomised phase III study in advanced breast cancer shows the combination of Xeloda (capecitabine)plus paclitaxel is equally as effective and safer ... Newswit.com Xeloda® Plus Cisplatin Combination Effective in Patients With... - Jun 15, 2006 ATLANTA -- In the first-ever Phase III trial of oral Xeloda (capecitabine) as first-line treatment for gastric cancer, Xeloda plus cisplatin (XP) was found ... EndoNurse Roche's Xeloda sees strong Ph III data.(Roche Holding Ltd.)(phase)(Bri... - Jun 12, 2006 Swiss drug major Roche says that results from the largest-ever Phase III study in advanced esophagogastric cancer, were presented at the American Society of ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Frustration for GPC oral cancer drug - Jul 26, 2007 By Anna Lewcock, 26-Jul-2007. GPC Biotech was dealt a blow this week as an advisory committee recommended that regulatory bodies should hold off on approval ... In-PharmaTechnologist.com Roche posts sustained double-digit sales growth for the first nine... - Oct 21, 2008 Commenting on the Group's sales performance in the first nine months of 2008, Roche CEO Severin Schwan said: 'The Roche Group maintained its strong growth ... webwire.com Avastin Curative Surgery Successful In Patients With Advanced … - Sep 26, 2007 High number of patients treated with Avastin plus standard chemotherapy for their colorectal cancer underwent complete surgical removal of their metastatic ... emaxhealth.com Eli Lilly Drug Shows Activity Across Multiple Cancer Types - Jun 6, 2006 New preclinical data have provided support for the activity of Eli Lilly's investigational oral agent enzastaurin in a number of difficult to treat and ... RedOrbit Studies Question Survival Benefit of Initial Aggressive Combination … - Jul 14, 2007 Two randomized trials published in the July 14, 2007 issue of The Lancet suggests that initial single agent therapy with 5-FU (fluorouracil) Xeloda ... Cancer Consultants Daily Cancer News - Dec 22, 2008 Among women with high-risk early breast cancer, the addition of Xeloda® (capecitabine) to a standard chemotherapy regimen reduces the risk of cancer ... Cancer Consultants |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |